Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1977 1
1978 1
1979 3
1980 2
1983 1
1984 1
1985 3
1986 1
1988 2
1990 5
1991 2
1992 2
1994 1
1995 2
1996 2
1997 9
1998 7
1999 8
2000 4
2001 4
2002 4
2003 3
2004 6
2005 10
2006 8
2007 6
2008 5
2009 6
2010 2
2011 4
2012 12
2013 5
2014 11
2015 11
2016 11
2017 9
2018 3
2020 2
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Results by year

Filters applied: . Clear all
Page 1
Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial.
Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, del Junco DJ, Brasel KJ, Bulger EM, Callcut RA, Cohen MJ, Cotton BA, Fabian TC, Inaba K, Kerby JD, Muskat P, O'Keeffe T, Rizoli S, Robinson BR, Scalea TM, Schreiber MA, Stein DM, Weinberg JA, Callum JL, Hess JR, Matijevic N, Miller CN, Pittet JF, Hoyt DB, Pearson GD, Leroux B, van Belle G; PROPPR Study Group. Holcomb JB, et al. Among authors: tilley bc. JAMA. 2015 Feb 3;313(5):471-82. doi: 10.1001/jama.2015.12. JAMA. 2015. PMID: 25647203 Free PMC article. Clinical Trial.
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N; Movement Disorder Society UPDRS Revision Task Force. Goetz CG, et al. Among authors: tilley bc. Mov Disord. 2008 Nov 15;23(15):2129-70. doi: 10.1002/mds.22340. Mov Disord. 2008. PMID: 19025984
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.
Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W; ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group; Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G. Lees KR, et al. Among authors: tilley bc. Lancet. 2010 May 15;375(9727):1695-703. doi: 10.1016/S0140-6736(10)60491-6. Lancet. 2010. PMID: 20472172
Economic analysis of secondary trial data.
Simpson KN, Tilley BC. Simpson KN, et al. Among authors: tilley bc. Prog Cardiovasc Dis. 2012 Jan-Feb;54(4):351-6. doi: 10.1016/j.pcad.2011.08.004. Prog Cardiovasc Dis. 2012. PMID: 22226003 Review.
Outcome variables in osteoporosis trials.
Kleerekoper M, Nelson DA, Peterson EL, Tilley BC. Kleerekoper M, et al. Among authors: tilley bc. Bone. 1992;13 Suppl 1:S29-34. doi: 10.1016/s8756-3282(09)80007-0. Bone. 1992. PMID: 1581116 Review.
Cost-effectiveness evaluation of the PROPPR trial transfusion protocols.
Callcut RA, Simpson KN, Baraniuk S, Fox EE, Tilley BC, Holcomb JB; PROPPR Study Group. Callcut RA, et al. Among authors: tilley bc. Transfusion. 2020 May;60(5):922-931. doi: 10.1111/trf.15784. Epub 2020 May 1. Transfusion. 2020. PMID: 32358836 Free PMC article. Clinical Trial.
175 results